Category:
Central Nervous System Drugs
CAS NO:
943319-70-8
Standard:
In-house Standards,

Ponatinib is a prescription medication used to treat a rare form of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myeloid leukemia (CML) that is resistant to other treatments.